
MaxCyte, Inc.
MXCTNASDAQHealthcare● Active
$1.15
+$0.01(+0.88%)
Market Cap$123189923
P/E Ratio—
52W High$2.38
52W Low$0.643
MaxCyte, Inc.(MXCT)· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · MXCT · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $103.04M | $154.48M | $168.29M | $227.34M | $255.04M |
| Net Receivables | $3.50M | $4.68M | $5.78M | $11.18M | $6.88M |
| Inventory | $7.55M | $8.91M | $12.23M | $8.58M | $5.20M |
| Total Current Assets | $118.37M | $171.68M | $190.19M | $252.27M | $270.43M |
| PP&E Net | $28.45M | $30.47M | $34.75M | $33.58M | $13.37M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.65M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $202.51M | $239.47M | $268.27M | $286.65M | $284.12M |
| Liabilities | |||||
| Short-Term Debt | $1.46M | $0.86M | $0.00M | $0.00M | $0.00M |
| Accounts Payable | $1.40M | $1.36M | $0.74M | $0.29M | $1.82M |
| Total Current Liabilities | $14.27M | $15.78M | $17.86M | $15.43M | $15.62M |
| Long-Term Debt | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Liabilities | $31.02M | $33.22M | $36.11M | $32.69M | $21.22M |
| Stockholders Equity | |||||
| Retained Earnings | ($261.48M) | ($216.85M) | ($175.80M) | ($137.88M) | ($114.30M) |
| Total Stockholders Equity | $171.49M | $206.25M | $232.17M | $253.97M | $262.90M |
| Total Liab & Equity(computed) | $202.51M | $239.47M | $268.27M | $286.65M | $284.12M |
| Debt Summary | |||||
| Total Debt | $17.94M | $18.03M | $18.74M | $16.09M | $5.68M |
| Net Debt | ($2.12M) | ($9.85M) | ($27.76M) | $5.03M | ($42.10M) |
数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · USD · M
深入了解MaxCyte, Inc.
关于MaxCyte, Inc.(MXCT)资产负债表
MaxCyte, Inc.总资产$0.20B,现金及短期投资$0.10B,总负债$0.03B,总债务$0.02B,股东权益$0.17B。
常见问题
MXCT · 4 问MaxCyte, Inc.总债务$0.02B,净债务($0.00B)。
MXCT total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10